Pubs | UCSF School of Medicine Department of Dermatology

Case report: Clinical and immunohistochemical manifestations of suspected Sjogren's disease in a dog. (39711802)

Story BD, Thomasy SM, Randolph MW, Vincek A, Martins B, Mills EP, Dear JD, Johnson EG, Jordan RC, Goldschmidt SL, Vapniarsky N PMID: 39711802

Global trends in immune mediated inflammatory diseases: Psoriasis, atopic dermatitis, multiple sclerosis, inflammatory bowel disease, and rheumatoid arthritis. (39834709)

Gelabert-Mora A, Chiang B, Lee A, Sinha M, Abuabara K PMID: 39834709

Brodalumab: Six-Year US Pharmacovigilance Report. (39589679)

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL, Mangin GD, Jacobson AA PMID: 39589679

An unusual oral manifestation of chronic lymphocytic leukemia: A case report and review of the literature. (39601734)

Lodolo M, Jordan R, Villa A PMID: 39601734

Skin cancer risk across racial/ethnic groups among solid organ transplant recipients in the United States, 2000-2022. (39579990)

Ojute F, Zakaria A, Zullo S, Klufas D, Amerson E PMID: 39579990

Impact of GLP-1 Receptor Agonists on Psoriasis and Cardiovascular Comorbidities: A Narrative Review. (39564576)

Haran K, Johnson CE, Smith P, Venable Z, Kranyak A, Bhutani T, Jeon C, Liao W PMID: 39564576

Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial. (39551064)

Mell LK, Torres-Saavedra PA, Wong SJ, Kish JA, Chang SS, Jordan RC, Liu T, Truong MT, Winquist EW, Takiar V, Wise-Draper T, Robbins JR, Rodriguez CP, Awan MJ, Beadle BM, Henson C, Narayan S, Spencer SA, Powell S, Dunlap N, Sacco AG, Hu KS, Park HS, Bauman JE, Harris J, Yom SS, Le QT PMID: 39551064